盐酸阿米洛利在人体内的代谢。 - Suppr

Suppr

超能文献

The meetabolism of amiloride hydroloride in man.

作者信息

Weiss P, Hersey R M, Dujovne C A, Bianchine J R

出版信息

Clin Pharmacol Ther. 1969 May-Jun;10(3):401-6. doi: 10.1002/cpt1969103401.

DOI:10.1002/cpt1969103401

PMID:5795809

Abstract

摘要

相似文献

The meetabolism of amiloride hydroloride in man.盐酸阿米洛利在人体内的代谢。

Clin Pharmacol Ther. 1969 May-Jun;10(3):401-6. doi: 10.1002/cpt1969103401.

Studies on the metabolism of -guanidinobutyric acid (HL 521) and its amide (HL 523).关于胍基丁酸（HL 521）及其酰胺（HL 523）代谢的研究。

Horm Metab Res. 1971 May;3(3):188-92. doi: 10.1055/s-0028-1094154.

The metabolic fate of the pteridine diuretic, Wy-5256.蝶啶类利尿剂Wy-5256的代谢转归

J Pharm Sci. 1969 Jul;58(7):867-71. doi: 10.1002/jps.2600580717.

4-guanidinobutyramide, a nonmetabolized pharmacologically active agent.

Arch Int Pharmacodyn Ther. 1972 May;197(1):14-8.

Methylguanidine in uremia.尿毒症中的甲基胍

Arch Intern Med. 1973 May;131(5):709-13.

The metabolism and excretion of guanoxan in man.胍生在人体内的代谢与排泄。

Xenobiotica. 1972 Jan;2(1):35-43. doi: 10.3109/00498257209036232.

Absorption, distribution and elimination of 14 C-amiloride in normal human subjects.14C-氨氯地平在正常人体受试者中的吸收、分布和消除。

Br J Pharmacol. 1971 Oct;43(2):473P-474P.

A new method for measuring guanidine in uremia.一种测量尿毒症中胍的新方法。

Experientia. 1973 Apr 15;29(4):506-7. doi: 10.1007/BF01926810.

Pharmacokinetics and metabolism of guanfacine in man: a review.胍法辛在人体中的药代动力学与代谢：综述

Br J Clin Pharmacol. 1980;10 Suppl 1(Suppl 1):25S-32S. doi: 10.1111/j.1365-2125.1980.tb04901.x.

Renal excretion of metolazone, a new diuretic.新型利尿剂美托拉宗的肾排泄

Br J Pharmacol. 1972 Jul;45(3):476-9. doi: 10.1111/j.1476-5381.1972.tb08104.x.

引用本文的文献

Distinguishing between the permeability relationships with absorption and metabolism to improve BCS and BDDCS predictions in early drug discovery.区分与吸收和代谢相关的渗透性，以改善早期药物发现中的BCS和BDDCS预测。

Mol Pharm. 2014 Apr 7;11(4):1335-44. doi: 10.1021/mp4007858. Epub 2014 Mar 28.

Amiloride: biological fluid analysis by reverse-phase HPLC.阿米洛利：反相高效液相色谱法的生物流体分析。

Pharm Res. 1985 May;2(3):143-5. doi: 10.1023/A:1016371618594.

K+ secretion in the rat kidney: Na+ channel-dependent and -independent mechanisms.大鼠肾脏中的钾离子分泌：依赖钠离子通道和不依赖钠离子通道的机制。

Am J Physiol Renal Physiol. 2009 Aug;297(2):F389-96. doi: 10.1152/ajprenal.90528.2008. Epub 2009 May 27.

Amiloride handling in renal failure.肾衰竭时氨氯吡咪的处理

Br J Clin Pharmacol. 1980 Jan;9(1):94-5. doi: 10.1111/j.1365-2125.1980.tb04803.x.

Clinical pharmacokinetics of diuretics.利尿剂的临床药代动力学

Clin Pharmacokinet. 1980 May-Jun;5(3):221-45. doi: 10.2165/00003088-198005030-00003.

Renal tubular secretion and effects of the alkaline diuretics amiloride, tizolemide (Hoe 740) and 2-aminomethyl-4(1,1-dimethylethyl)-6-iodophenol hydrochloride (MK-447).肾小管分泌以及碱性利尿剂阿米洛利、替唑利米（Hoe 740）和盐酸2-氨甲基-4-（1,1-二甲基乙基）-6-碘苯酚（MK-447）的作用

Naunyn Schmiedebergs Arch Pharmacol. 1981;317(4):357-63. doi: 10.1007/BF00501319.

Drug interferences with plasma assays in therapeutic drug monitoring.治疗药物监测中药物对血浆分析的干扰。

Clin Pharmacokinet. 1984 Jan-Feb;9(1):67-87. doi: 10.2165/00003088-198409010-00004.

Absorption, distribution and elimination of 14 C-amiloride in normal human subjects.14C-氨氯地平在正常人体受试者中的吸收、分布和消除。

Br J Pharmacol. 1971 Oct;43(2):473P-474P.

Kinetics and bioavailability of two formulations of amiloride in man.氨氯吡咪两种制剂在人体中的动力学和生物利用度

Br J Pharmacol. 1973 Aug;48(4):646-9.

Short term effects and urinary excretion of the new diuretic, indapamide, in normal subjects.

Eur J Clin Pharmacol. 1974 Oct 4;7(6):407-14. doi: 10.1007/BF00560352.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验